Splanchnic PGI2 release and "no reflow" following intestinal reperfusion.
Splanchnic PGI2 release and "no reflow" following intestinal reperfusion.
复制标题
肠道再灌注后内脏 PGI2 释放且“无回流”。
DOI:
10.1006/jsre.1995.1088
复制
发表时间:
1995
期刊:
影响因子:
--
通讯作者:
Myers,SI
中科院分区:
文献类型:
--
作者:
Turnage,RH;Kadesky,KM;Bartula,L;Guice,KS;Oldham,KT;Myers,SI
This study examines the hypothesis that reduced splanchnic blood flow during intestinal reperfusion (IR) is associated with impaired release of the vasodilatory prostanoid PGI2. Sprague-Dawley rats underwent occlusion of the superior mesenteric artery (SMA) for 120 min and reperfusion for up to 60 min. SMA blood flow was measured by transonic flow probe and radiolabeled microspheres (141Ce and103Ru). Sham-operated animals served as controls (SHAM). Splanchnic eicosanoid release was quantitated by measuring thromboxane B2(TxB2, stable metabolite of TxA2), 6-keto-PGF1a(6-keto, stable metabolite of PCI2), and PGE2within the portal vein (PV) and inferior vena cava (IVC) of animals sustaining IR and SHAM. SMA flow in IR animals was <10% of baseline and 27% of SHAM when measured by transonic flow probe (8 ± 2% and 29 ± 3%, IR and SHAM, respectively, P < 0.05). Similar results were obtained when intestinal blood flow was measured with microspheres (0.33 ± 0.12 vs 1.34 ± 0.13 ml/min/g, IR vs SHAM, P < 0.05). The greatest change in IR-induced splanchnic eicosanoid release occurred with 6-keto. Following ischemia, 6-keto levels in the PV were twice those of SHAM (P < 0.05). Five minutes after reperfusion, PV 6-keto levels were 22 times those of controls (P < 0.05) and 4 times greater than those of the IVC (P < 0.05). By 60 min of reperfusion, levels of 6-keto were reduced to those in the IVC. These data support the hypothesis that splanchnic blood flow is critically reduced by severe IR. Furthermore, although splanchnic PGI2release is increased, its release is neither sustained nor adequate to compensate for the reduced blood flow associated with this injury model.